Akira Yokomizo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Smoking Cessation

Radical Prostatectomy

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Future oncology (London, England)

Cancer medicine

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Koichiro Akakura, Hiroji Uemura, Satoru Kawakami, Akira Yokomizo, Motonobu Nakamura, Kazuo Nishimura, Tetsushi Komori, Dianne Athene Ledesma
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan. Future oncology (London, England) 20 (12) (2024)
Masashi Kato, Masaki Shiota, Takahiro Kimura, Ryoichi Hanazawa, Akihiro Hirakawa, Dai Takamatsu, Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito, Akira Yokomizo, Yoshiyuki Yamamoto, Shintaro Narita, Kohei Hashimoto, Hiroaki Matsumoto, Shusuke Akamatsu, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, Toyonori Tsuzuki, null null
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Masashi Kato, Masaki Shiota, Takahiro Kimura, Ryoichi Hanazawa, Akihiro Hirakawa, Dai Takamatsu, Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito, Akira Yokomizo, Yoshiyuki Yamamoto, Shintaro Narita, Kohei Hashimoto, Hiroaki Matsumoto, Shusuke Akamatsu, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, Toyonori Tsuzuki, null null
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Koichiro Akakura, Hiroji Uemura, Satoru Kawakami, Akira Yokomizo, Motonobu Nakamura, Kazuo Nishimura, Tetsushi Komori, Dianne Athene Ledesma
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan. Future oncology (London, England) (2024)
Koichiro Akakura, Hiroji Uemura, Satoru Kawakami, Akira Yokomizo, Motonobu Nakamura, Kazuo Nishimura, Tetsushi Komori, Dianne Athene Ledesma
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan. Future oncology (London, England) 20 (12) (2024)
Masashi Kato, Masaki Shiota, Takahiro Kimura, Ryoichi Hanazawa, Akihiro Hirakawa, Dai Takamatsu, Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito, Akira Yokomizo, Yoshiyuki Yamamoto, Shintaro Narita, Kohei Hashimoto, Hiroaki Matsumoto, Shusuke Akamatsu, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, Toyonori Tsuzuki, null null
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort. International journal of urology : official journal of the Japanese Urological Association (2024)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Katsuhiro Ito, Yuki Kita, Akira Yokomizo, Jun Miki, Yuko Yoshio, Hiroaki Matsumoto, Takehiko Segawa, Takashi Karashima, Naotaka Nishiyama, Kazuto Imai, Shigetaka Suekane, Seiji Nagasawa, Shin Higashi, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi
Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study. Cancer medicine (2022)
Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, Yoichiro Tohi, Jimpei Miyakawa, Koji Mitsuzuka, Hiroshi Sasaki, Junichi Inokuchi, Masafumi Matsumura, Shinichi Sakamoto, Hidefumi Kinoshita, Hiroshi Fukuhara, Naoto Kamiya, Ryu Kimura, Masahiro Nitta, Hiroshi Okuno, Koichiro Akakura, Yoshiyuki Kakehi, Mikio Sugimoto
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study. International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)
Katsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, Kensuke Hikami, Takeshi Yamada, Kosuke Ogawa, Kenji Nakamura, Naoto Sassa, Akira Yokomizo, Takashige Abe, Kazunari Tsuchihashi, Shuichi Tatarano, Junichi Inokuchi, Ryotaro Tomida, Maki Fujiwara, Atsushi Takahashi, Kazumasa Matsumoto, Kosuke Shimizu, Hiromasa Araki, Ryoma Kurahashi, Yu Osaki, Yu Tashiro, Masayuki Uegaki, Osamu Ogawa, Hiroshi Kitamura, Hiroyuki Nishiyama
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort. Cancer medicine 10 (10) (2021)
Akira Yokomizo, Hirofumi Koga, Kazuto Ito, Yutaka Takezawa, Motokiyo Komiyama, Kazuo Nishimura, Junji Yonese, Katsuyoshi Hashine, Naoya Masumori, Gaku Arai, Shiro Saito, Mitsuru Shinohara, Nobuaki Shimizu, Atsushi Yamauchi, Takefumi Satoh, Tatsuo Tochigi, Mikio Kobayashi, Hiroyuki Fujimoto, Ken-Ichi Kakimoto, Iwao Fukui, Taiji Tsukamoto, Miwako Nozaki, Katsuyuki Karasawa, Masaru Hasumi, Mikinobu Ohtani, Hiromichi Ishiyama, Masaaki Kuwahara, Masaoki Harada, Yasuo Ohashi, Toshihiko Kotake, Tadao Kakizoe, Kazuhiro Suzuki, Seiji Naito, Hidetoshi Yamanaka, null null
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial. Cancer medicine 10 (10) (2021)
Akira Yokomizo, Junji Yonese, Shin Egawa, Hiroshi Fukuhara, Hiroji Uemura, Kazuo Nishimura, Masayoshi Nagata, Atsushi Saito, Takumi Lee, Susumu Yamaguchi, Norio Nonomura
Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan. International journal of clinical oncology (2021)